FTC Wins AndroGel Info From AbbVie In Antitrust Suit
By Eric Kroh ( August 11, 2016, 7:26 PM EDT) -- A Pennsylvania federal judge on Thursday ordered AbbVie to hand over to the U.S. Federal Trade Commission documents from its board of directors concerning the marketing of testosterone treatment AndroGel in a pay-for-delay suit brought by the agency....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.